CompletedNot Applicable

Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations

Netherlands64 participantsStarted 2022-10-06

Plain-language summary

A single arm intervention study examining ONS-flavour preference in cancer patients with and without taste alterations

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Being diagnosed with cancer
✓. Undergoing, or having undergone systemic anti-cancer treatment or radiotherapy in the past 12 months.
✓. Age \> 18 years
✓. Written informed consent

✕. Taste and smell alterations not caused by the cancer or anti-cancer treatment
✕. Galactosaemia
✕. Use of thickener to be able to swallow safely
✕. Allergies to any of the product ingredients or any of the flavours
✕. Current prescription for ONS, enteral nutrition or parenteral nutrition
✕. Diabetes mellitus Type I or Type II
✕. Open sores or severe inflammation in the mouth or throat
✕. Undergoing dialysis

Choice for the Fortimel/Nutridrink Compact Protein sensation flavour over the Fortimel/Nutridrink Compact Protein regular flavour

Timeframe: On 4 days

NCT IDNCT05518825

SponsorNutricia Research

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-03-28